What Happened When Apellis Pharmaceuticals Added a New Board Member in April 2025

Apellis Pharmaceuticals appointed a new board member in April 2025

Apellis Pharmaceuticals, a biopharmaceutical company focused on complement-driven diseases, announced a board appointment in April 2025. The company added Carla Harris to its board of directors. Harris is a managing director and senior client advisor at Morgan Stanley, with a background in investment banking and healthcare sector expertise.

Board appointments at public companies like Apellis are disclosed through regulatory filings with the Securities and Exchange Commission (SEC). These announcements are public record and typically appear in the company's investor relations materials, press releases, and official SEC documents. Understanding what a board appointment means and where to find details about it can help you track company leadership changes if you hold stock, work in the industry, or monitor pharmaceutical sector developments.

Key Takeaways

• Apellis Pharmaceuticals added Carla Harris, a Morgan Stanley managing director, to its board of directors in April 2025.
• Board appointments at public companies are disclosed through SEC filings, which are available free on the SEC's EDGAR database.
• A board member's background in investment banking and healthcare can signal the company's strategic direction and focus areas.
• You can track board changes and other company announcements through the company's investor relations website or SEC filings.

Where board appointment information is publicly filed

When a public company appoints a new board member, it must report this change to the SEC within four business days through a Form 8-K (Current Report). This form discloses material events that shareholders should know about, including changes in the board of directors. The Form 8-K includes the new director's name, age, background, and any relevant business experience.

You can find Apellis Pharmaceuticals' SEC filings on the EDGAR database (Electronic Data Gathering, Organization, and Retrieval), which is free and searchable by company name or ticker symbol. The company's ticker is APLS. Simply search for Apellis, then filter by Form 8-K filings from April 2025 to locate the official announcement. The company also typically posts a press release about the appointment on its investor relations website.

Carla Harris's background and why it matters

Carla Harris has spent her career in investment banking and healthcare finance. At Morgan Stanley, she advises healthcare companies on mergers, acquisitions, and capital strategy. Her expertise in the healthcare sector and her experience advising pharmaceutical and biotech firms make her a relevant addition to Apellis's board, particularly as the company navigates growth, partnerships, and market positioning.

Board members bring specific skills and networks to a company. Harris's investment banking background suggests Apellis may be considering strategic transactions, seeking to strengthen relationships with financial institutions, or planning capital-raising activities. Board appointments often reflect where a company is heading strategically, so tracking who joins the board can give insight into the company's priorities.

What a board member does

A board of directors oversees a company's management, sets strategic direction, and ensures the company operates in shareholders' interests. Board members attend regular meetings, review financial performance, approve major decisions, and provide guidance to the CEO and executive team. They also serve on committees focused on specific areas like audit, compensation, or nominating new directors.

Board members have a legal duty to act in good faith and in the company's best interest. They are not employees and typically receive compensation in the form of cash, stock, or both. The size and composition of a board varies by company, but most public companies have between 7 and 15 directors with a mix of industry expertise, financial knowledge, and operational experience.

How to track board changes at Apellis

If you own Apellis stock or follow the company for work or investment reasons, you can monitor board changes through several sources. The company's investor relations website (usually found under "About Us" or "Investors" on the main website) publishes press releases about major announcements, including board appointments. You can also subscribe to SEC filing alerts through EDGAR or use financial news websites that track corporate announcements.

Apellis's annual proxy statement (Form DEF 14A), filed before the annual shareholder meeting, lists all current board members, their backgrounds, and their committee assignments. This document is also available on EDGAR and provides the most complete picture of the board's composition at any given time. Proxy statements are typically filed in the spring of each year.

Board composition and diversity considerations

Public companies increasingly disclose information about board diversity, including gender, race, and professional background. The SEC has expanded disclosure requirements in recent years to give shareholders more visibility into board composition. Apellis, like other public companies, reports on its board's diversity in its proxy statement and corporate governance materials.

Harris's appointment adds to the board's overall experience in finance and healthcare strategy. Companies often seek board members who bring different perspectives and expertise, which can improve decision-making and reduce risk. The addition of a senior investment banker to a biotech board is a common move, particularly for companies in growth phases or considering significant strategic moves.

Frequently Asked Questions

Where can I find the official announcement of Carla Harris joining Apellis's board?

Search the SEC's EDGAR database for Apellis Pharmaceuticals (ticker APLS) and look for Form 8-K filings from April 2025. You can also visit Apellis's investor relations website, where the company typically posts a press release about the appointment. Both sources are free and publicly available.

What does a board member actually do day-to-day?

Board members do not work at the company full-time. They attend quarterly board meetings, review financial reports and strategic plans, and serve on committees. They provide advice to the CEO and executive team, approve major decisions, and ensure the company follows laws and regulations. Most board members spend 10 to 20 hours per month on board duties.

Why would a pharmaceutical company add an investment banker to its board?

Investment bankers bring expertise in mergers, acquisitions, financing, and capital strategy. A biotech company may add someone with this background if it is considering partnerships, acquisitions, or raising capital. Harris's experience advising healthcare companies makes her particularly relevant to Apellis's strategic planning.

How often do board members change at public companies?

Board composition changes regularly as directors retire, step down, or are not re-nominated. Most public companies have some board turnover each year. Changes are disclosed through Form 8-K filings and are part of normal corporate governance. You can track these changes by monitoring SEC filings or the company's investor relations announcements.

Can I see a full list of Apellis's current board members?

Yes. The company's proxy statement (Form DEF 14A), filed annually before the shareholder meeting, lists all board members, their ages, backgrounds, and committee assignments. This document is available on EDGAR and on Apellis's investor relations website. The proxy statement is the most complete source for board information.